Founded in 1998, Gan&Lee Pharmaceuticals is a high-tech biopharmaceutical company integrating R&D, production and commercialization. Headquatered in Beijing, Gan & Lee has an industrial park of about 200,000 square meters and more than 4000 employees. As the first Chinese company with the technology of recombinant insulin analogues, Gan & Lee is definitely a market leader in China. Globally, Gan & Lee has established close collaboration with famous enterprises like Sandoz. Today, focusing on human healthcare, Gan & Lee is committed to providing high-quality products and services for diabetes patients worldwide.
more >
Year of Establishment:
1998
Total Assets(USD):
Total Number of Staff:
more than 1000
Main Competitive Advantages:
International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
OEM,Own Brand
Annual Turnover(USD):
More than 99,999,999
Main Sales Markets:
Central/South America,Asia,Middle East
Other Competitive Advantages:
Patents and Copyrights: